Hannah - you&me, neverending history 💜

Oncology APRN NP, solid tumors- GI (pancreas), 🧬 hereditary cancers. Music lover 🎶 Enthusiastic fangirl 🐹 ⟭⟬ ⊙⊝⊜! Opinions are my own.

[Hannah - you&me, neverending history 💜 @HannahAlison20]

RASolute 302 created an emotional plenary session.

For anyone who has had the privilege of caring for pancreatic cancer patients and their families- a trial with a doubling of overall survival in the setting of advanced disease is nothing short of remarkable.

We must continue to have #HOPE for #PDAC because look where we are today!

#ASCO2026
#RAS
#Pancreaticcancerawareness
#KEEPSWIMMING

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

New study looking at the Impact of #BreastCancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Women with Pathogenic BRCA1/2 Variants.
https://t.co/66doeBiTJj
@judygarber5

[FOR BTS JIN (김석진번역팀) @for_seokjin1992]

@secawards CONGRATULATIONS JIN

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@DazzledxHyunjin Or he could show up at a pancreas conference with data about screening methodologies- that would grab my attention too 😅

[John P Erwin III MD MBA MACC (#BigPoppy ) @HeartOTXHeartMD]

Outstanding article!

I wholeheartedly endorse!

“In a 2009 study of academic faculty physicians, researchers measured how much time each person spent on the activity they found most meaningful, then measured burnout. The pattern was stark. Physicians who spent less than 20% of their time on that activity had a burnout rate of 53.8%. Those at or above 20% sat at 29.9%. Time on the most meaningful work was the strongest predictor of burnout in the analysis, ahead of total hours worked. (Shanafelt and colleagues, Archives of Internal Medicine, 2009.)”

[Yüksel Ürün @DrYukselUrun]

Not every biomarker is ready for the clinic.
The real question is simple: does it change care?
Such a great talk by @karima_oualla on biomarkers in UC.
@DrOmarMian @bergsa83 @BradMcG04 @IMyrtaly @gbanna74 @DrYukselUrun @brian_rini @tompowles1 @fredhutch @OncoAlert @shilpaonc @EvanHallMD @FunchainMD @ManiamAkash @PGrivasMDPhD @Uromigos @urologysummit

[seokjin pics that go 𝒽𝒶𝓇𝒹 @_rockstarjin]

"do your idols go viral for being shirtless?"

seokjin:

[Hannah - you&me, neverending history 💜 @HannahAlison20]

Amazing #TumorBoardTuesday. Excellent discussion. I came away understanding the trial, this combination, and possible promising future avenues this study opens. Plus I had a fangirl moment with the brightest stars in Colorectal cancer care. My week is made! Thank you @CathyEngMD and @SpenceLessansMD

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@TumorBoardTues @SpenceLessansMD @CathyEngMD @IntegrityCE It's how we are going to get BTS JIN to join #TumorBoardTuesday someday. It's going to happen. I have faith, I know it!

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@CathyEngMD @SpenceLessansMD @TumorBoardTues @IntegrityCE Yes!!
I miss it and Catherine O'Hara 😢

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@SpenceLessansMD @TumorBoardTues @CathyEngMD @IntegrityCE 💙💙💙
This is what it's all about.
Best part of #TumorBoardTuesday, not a graph showing separation of a curve but the practical, real life experience for the patient who certainly has been through enough treatment to know!

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@CathyEngMD @SpenceLessansMD @TumorBoardTues @IntegrityCE That's probably the most impressive and essential point too!
#TumorBoardTuesday

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@SpenceLessansMD @TumorBoardTues @CathyEngMD @IntegrityCE At first glance, that isn't a huge difference, but again, this is a heavily pre-treated, MSS population and we have to start somewhere with new options and if quality of life was maintained then... #TumorBoardTuesday.

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@CathyEngMD @SpenceLessansMD @TumorBoardTues @IntegrityCE #TumorBoardTuesday is usually ahead of its time, this is where we talked about Claduin 18.2 and zolbetuximab trials and then it was approved soon after. Maybe TBT brings good luck?

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@SpenceLessansMD @TumorBoardTues @CathyEngMD @IntegrityCE I should have guessed hypertension now that I realize zanza includes VEGFR inhibition. #TumorBoardTuesday.

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@SpenceLessansMD @TumorBoardTues @CathyEngMD @IntegrityCE When they say multikinase- they aren't kidding! #TumorBoardTuesday

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@SpenceLessansMD @TumorBoardTues @CathyEngMD @IntegrityCE Because I can't go an episode of #TumorBoardTuesday without mentioning pancreas cancer, I have read that PDAC metastatic to lung often has better prognosis than PDAC metastatic to liver and wonder if this is the same reason.

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@MPishvaian @SpenceLessansMD @TumorBoardTues @CathyEngMD @IntegrityCE Great point!
#TumorBoardTuesday

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@CathyEngMD @SpenceLessansMD @TumorBoardTues @IntegrityCE That doubles the excitement!
#TumorBoardTuesday

[Hannah - you&me, neverending history 💜 @HannahAlison20]

@CathyEngMD @SpenceLessansMD @TumorBoardTues @IntegrityCE @hannah @agenus Thank you!!!